Roscovitine attenuates renal interstitial fibrosis in diabetic mice through the TGF-β1/p38 MAPK pathway. [electronic resource]
Producer: 20200114Description: 108895 p. digitalISSN:- 1950-6007
- Animals
- Cell Line
- Diabetes Mellitus, Experimental -- drug therapy
- Diabetic Nephropathies -- metabolism
- Dose-Response Relationship, Drug
- Epithelial-Mesenchymal Transition -- drug effects
- Fibrosis
- Humans
- Kidney -- drug effects
- Kidney Function Tests
- Male
- Mice, Inbred Strains
- Roscovitine -- therapeutic use
- Signal Transduction -- drug effects
- Streptozocin
- Transforming Growth Factor beta -- metabolism
- p38 Mitogen-Activated Protein Kinases -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.